These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 20472432)

  • 21. Traceless solid-phase synthesis of 2,4,6-trisubstituted thiazolo[4,5-d]pyrimidine-5,7-dione derivatives.
    Lee T; Park JH; Lee DH; Gong YD
    J Comb Chem; 2009; 11(3):495-9. PubMed ID: 19338271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of structure-derived pharmacophore of soluble epoxide hydrolase inhibitors by virtual screening.
    Moser D; Achenbach J; Klingler FM; Estel la B; Hahn S; Proschak E
    Bioorg Med Chem Lett; 2012 Nov; 22(21):6762-5. PubMed ID: 23017883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacophoric modeling and atom-based 3D-QSAR of novel 1-aryl-3-(1-acylpiperidin-4-yl) urea as human soluble epoxide hydrolase inhibitors (sEHIs).
    Das N; Dhanawat M; Kulshrestha A; Shrivastava SK
    Med Chem; 2011 Nov; 7(6):581-92. PubMed ID: 22313298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peptidyl-urea based inhibitors of soluble epoxide hydrolases.
    Morisseau C; Newman JW; Tsai HJ; Baecker PA; Hammock BD
    Bioorg Med Chem Lett; 2006 Oct; 16(20):5439-44. PubMed ID: 16908134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insights into the structure of urea-like compounds as inhibitors of the juvenile hormone epoxide hydrolase (JHEH) of the tobacco hornworm Manduca sexta: analysis of the binding modes and structure-activity relationships of the inhibitors by docking and CoMFA calculations.
    Garriga M; Caballero J
    Chemosphere; 2011 Mar; 82(11):1604-13. PubMed ID: 21134691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploring the size of the lipophilic unit of the soluble epoxide hydrolase inhibitors.
    Codony S; Valverde E; Leiva R; Brea J; Isabel Loza M; Morisseau C; Hammock BD; Vázquez S
    Bioorg Med Chem; 2019 Oct; 27(20):115078. PubMed ID: 31488357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potent urea and carbamate inhibitors of soluble epoxide hydrolases.
    Morisseau C; Goodrow MH; Dowdy D; Zheng J; Greene JF; Sanborn JR; Hammock BD
    Proc Natl Acad Sci U S A; 1999 Aug; 96(16):8849-54. PubMed ID: 10430859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of enantioselectivity of urea inhibitors of soluble epoxide hydrolase.
    Manickam M; Pillaiyar T; Boggu P; Venkateswararao E; Jalani HB; Kim ND; Lee SK; Jeon JS; Kim SK; Jung SH
    Eur J Med Chem; 2016 Jul; 117():113-24. PubMed ID: 27092411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimization of amide-based inhibitors of soluble epoxide hydrolase with improved water solubility.
    Kim IH; Heirtzler FR; Morisseau C; Nishi K; Tsai HJ; Hammock BD
    J Med Chem; 2005 May; 48(10):3621-9. PubMed ID: 15887969
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combinatorial library design from reagent pharmacophore fingerprints.
    Chen H; Engkvist O; Blomberg N
    Methods Mol Biol; 2011; 685():135-52. PubMed ID: 20981522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A practical use of ligand efficiency indices out of the fragment-based approach: ligand efficiency-guided lead identification of soluble epoxide hydrolase inhibitors.
    Tanaka D; Tsuda Y; Shiyama T; Nishimura T; Chiyo N; Tominaga Y; Sawada N; Mimoto T; Kusunose N
    J Med Chem; 2011 Feb; 54(3):851-7. PubMed ID: 21192659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combinatorial approach toward synthesis of small molecule libraries as bacterial transglycosylase inhibitors.
    Shih HW; Chen KT; Chen SK; Huang CY; Cheng TJ; Ma C; Wong CH; Cheng WC
    Org Biomol Chem; 2010 Jun; 8(11):2586-93. PubMed ID: 20485795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imidazolidine-2,4,5- and pirimidine-2,4,6-triones - New primary pharmacophore for soluble epoxide hydrolase inhibitors with enhanced water solubility.
    Burmistrov V; Morisseau C; D'yachenko V; Karlov D; Butov GM; Hammock BD
    Bioorg Med Chem Lett; 2020 Feb; 30(3):126908. PubMed ID: 31870649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure-activity relationships of amide-phosphonate derivatives as inhibitors of the human soluble epoxide hydrolase.
    Kim IH; Park YK; Nishiwaki H; Hammock BD; Nishi K
    Bioorg Med Chem; 2015 Nov; 23(22):7199-210. PubMed ID: 26507430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioisosteric substitution of adamantane with bicyclic lipophilic groups improves water solubility of human soluble epoxide hydrolase inhibitors.
    Burmistrov V; Morisseau C; Karlov D; Pitushkin D; Vernigora A; Rasskazova E; Butov GM; Hammock BD
    Bioorg Med Chem Lett; 2020 Sep; 30(18):127430. PubMed ID: 32736212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure-based optimization of arylamides as inhibitors of soluble epoxide hydrolase.
    Eldrup AB; Soleymanzadeh F; Taylor SJ; Muegge I; Farrow NA; Joseph D; McKellop K; Man CC; Kukulka A; De Lombaert S
    J Med Chem; 2009 Oct; 52(19):5880-95. PubMed ID: 19746975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insight into the binding modes and inhibition mechanisms of adamantyl-based 1,3-disubstituted urea inhibitors in the active site of the human soluble epoxide hydrolase.
    Chen H; Zhang Y; Ye C; Feng TT; Han JG
    J Biomol Struct Dyn; 2014; 32(8):1231-47. PubMed ID: 23815795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure-activity relationships of substituted oxyoxalamides as inhibitors of the human soluble epoxide hydrolase.
    Kim IH; Lee IH; Nishiwaki H; Hammock BD; Nishi K
    Bioorg Med Chem; 2014 Feb; 22(3):1163-75. PubMed ID: 24433964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, synthesis and evaluation of non-urea inhibitors of soluble epoxide hydrolase.
    Pecic S; Deng SX; Morisseau C; Hammock BD; Landry DW
    Bioorg Med Chem Lett; 2012 Jan; 22(1):601-5. PubMed ID: 22079754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. From a multipotent stilbene to soluble epoxide hydrolase inhibitors with antiproliferative properties.
    Buscató E; Büttner D; Brüggerhoff A; Klingler FM; Weber J; Scholz B; Zivković A; Marschalek R; Stark H; Steinhilber D; Bode HB; Proschak E
    ChemMedChem; 2013 Jun; 8(6):919-23. PubMed ID: 23596124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.